Examinant per Autoria "Goeldner, Celia"
Mostrant 1 - 2 de 2
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome(BioMed Central, 2022) Goeldner, Celia; Kishnani, Priya; Skotko, Brian G.; Lirio Casero, Julian; Hipp, Joerg F.; Derks, Michael; Hernandez, Maria-Clemencia; Khwaja, Omar; Lennon-Chrimes, Sian; Noeldeke, Jana; Pellicer, Sabine; Squassante, Lisa; Visootsak, Jeannie; Wandel, Christoph; Fontoura, Paulo; Liogier d'Ardhuy, Xavier; Clematis Study Group
Ítem Accés Obert Assessment of cognitive Scales to examine memory, executive function and language in individuals with down syndrome: implications of a 6-month bservational study.(Frontiers, 2015) Liogier d'Ardhuy, Xavier; Edgin, Jamie O.; Bouis, Charles; Sola Llopis, Susana de; Goeldner, Celia; Kishnani, Priya; Nöldeke, Jana; Rice, Sydney; Sacco, Silvia; Squassante, Lisa; Spiridigliozzi, Gail; Visootsak, Jeannie; Heller, James; Khwaja, Omar